A Drone Expert Is Making Flying Cars Real

The Flash Report

26 Mar 2026 — 1 min read

In 2016, after years working on military drones, Doron Merdinger began sketching a flying car. He saw how quickly the tech had advanced. Soon, people would fly from driveways. So he built Doroni.

It’s great timing, too. The urban air mobility market is worth $4B today. By 2040, Morgan Stanley puts it at $1 trillion. By 2050, $9 trillion.

And with 600+ reservations for Doroni’s aircraft and $175M+ in potential revenue already, the demand for this innovation is undeniable.

But that's only scratching the surface of why 4,000+ investors have already joined.

Disruption: The H1-X is purpose-built for personal ownership while competitors chase commercial contracts, capturing a market segment most are overlooking.
Technology: Their SOUL.AI™ platform makes personal flight intuitive and safe, setting Doroni apart with intelligent systems competitors don't have.
Opportunity: For a limited time, Doroni is offering everyday investors the chance to join and unlock up to 25% bonus stock.

Now, they’re preparing to unveil a full-sized showroom prototype of their H1-X personal aircraft on March 26.

With commercial deliveries slated for 2028 and $1.4B in annual revenue projected by 2032, the timing of this raise couldn't be better.

The last time Doroni was open to investors, the opportunity maxed out in less than 100 days.

Claim your early-stage Doroni stake before this limited-time bonus window closes.

This is a paid advertisement for Doroni Regulation A offering. Please read the offering circular at https://invest.doroni.io/

The Biggest Unsolved Problem in Medicine?

Today, over half a billion people battle osteoarthritis. Each year, they spend $240B trying to halt the destruction of joint cartilage. But no cure exists on the market. Not for lack of trying, either. Big Pharma’s spent billions failing. Thankfully, Cytonics may have cracked the code. They discovered the

What if David and Goliath teamed up instead?

That’s what’s currently playing out in the foodservice industry, where industry goliaths Sodexo, Aramark, and Compass Group all partnered with foodtech startup Automated Retail Technologies. Why did they choose ART? With more than 150,000 venues managed by that trio alone, staffing overnight operations is costly and complicated.

The Key to This $500B Market Is in Your Bloodstream

Every year, $240B is spent on treating the symptoms of osteoarthritis, a disease that leads to joint degradation and, eventually, immobility. With 500M people afflicted, its total addressable market is worth over $500B. But not a single therapy has been able to actually stop it. The answer, it turns out,

Superhuman' Pre-IPO Stock Trading Under $1

Have you heard about this sub $1 Pre-IPO company that is making people "Superhumans"? It's all thanks to their new product called Visor. And it's very similar to Jarvis from the movie Iron Man. Investors are calling this a 'massive breakthrough'. But

Read more

The Biggest Unsolved Problem in Medicine?

What if David and Goliath teamed up instead?

The Key to This $500B Market Is in Your Bloodstream

Superhuman' Pre-IPO Stock Trading Under $1